Skip to main content

WR Markesbery

First name:
WR
Last name:
Markesbery
Huang, Q., Aluise, C., Joshi, G., Sultana, R., St Clair, D., Markesbery, W., & Butterfield, D. (2010). Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment. Journal of Neuroscience Research, 88(12), 2618-29. https://doi.org/10.1002/jnr.22422
Aluise, C., Robinson, R., Cai, J., Pierce, W., Markesbery, W., & Butterfield, D. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer’s disease: insights into memory loss in MCI. Journal of Alzheimer’s Disease : JAD, 23(2), 257-69. https://doi.org/10.3233/JAD-2010-101083 (Original work published 2011)
Russell, M., White, R., Patel, E., Markesbery, W., Watson, C., & Geddes, J. (1992). Familial influence on plaque formation in the beagle brain. Neuroreport, 3(12), 1093-6. https://doi.org/10.1097/00001756-199212000-00015
Tekirian, T., Cole, G., Russell, M., Yang, F., Wekstein, D., Patel, E., … Geddes, J. (1969). Carboxy terminal of beta-amyloid deposits in aged human, canine, and polar bear brains. Neurobiology of Aging, 17(2), 249-57. https://doi.org/10.1016/0197-4580(95)02062-4 (Original work published 1969)
Geddes, J., Tekirian, T., Soultanian, N., Ashford, J., Davis, D., & Markesbery, W. (1969). Comparison of neuropathologic criteria for the diagnosis of Alzheimer’s disease. Neurobiology of Aging, 18(4 Suppl), S99-105. https://doi.org/10.1016/s0197-4580(97)00063-8 (Original work published 1969)
Tekirian, T., Saido, T., Markesbery, W., Russell, M., Wekstein, D., Patel, E., & Geddes, J. (1998). N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits. Journal of Neuropathology and Experimental Neurology, 57(1), 76-94. https://doi.org/10.1097/00005072-199801000-00009
Aksenov, M., Aksenova, M., Butterfield, D., Geddes, J., & Markesbery, W. Protein oxidation in the brain in Alzheimer’s disease. Neuroscience, 103(2), 373-83. https://doi.org/10.1016/s0306-4522(00)00580-7 (Original work published 2001)
Blalock, E., Geddes, J., Chen, K., Porter, N., Markesbery, W., & Landfield, P. (2004). Incipient Alzheimer’s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proceedings of the National Academy of Sciences of the United States of America, 101(7), 2173-8. https://doi.org/10.1073/pnas.0308512100 (Original work published 2004)
Robinson, R., Joshi, G., Huang, Q., Sultana, R., Baker, A., Cai, J., … Butterfield, D. (2011). Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild... Proteomics, 11(21), 4243-56. https://doi.org/10.1002/pmic.201000523
Aksenov, M., Tucker, H., Nair, P., Aksenova, M., Butterfield, D., Estus, S., & Markesbery, W. (1998). The expression of key oxidative stress-handling genes in different brain regions in Alzheimer’s disease. Journal of Molecular Neuroscience : MN, 11(2), 151-64. https://doi.org/10.1385/JMN:11:2:151